Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Cariou

Showing results (41-50 of 311) with videos related to

Pageof 32
Sort By:
Journal of Clinical Lipidology|April 11, 2017
Severe decrease in high-density lipoprotein cholesterol with the combination of fibrates and ezetimibe: A case seriesEstelle Nobecourt, Bertrand Cariou, Gilles Lambert, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 22, 2021
Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: A narrative reviewSamuel Frey, Éric Mirallié, Bertrand Cariou, et al.
Current Opinion in Lipidology|April 19, 2015
Role of PCSK9 beyond liver involvementBertrand Cariou, Karim Si-Tayeb, Cédric Le May
Frontiers in Endocrinology|November 14, 2018
Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of GlucoseSimon Ducheix, Jocelyne Magré, Bertrand Cariou, et al.
Diabetes Care|April 24, 2025
Response to Comment on Christiaens et al. Diabetes Overtreatment and Hypoglycemia in Older Patients With Type 2 Diabetes on Insulin Therapy: Insights From the HYPOAGE Cohort Study. Diabetes Care 2025;48:61-66Antoine Christiaens, Anne-Sophie Boureau, Samy Hadjadj, et al.
Medecine Sciences : M/S|October 15, 2014
[Trans-intestinal cholesterol excretion (TICE): a new route for cholesterol excretion]Claire Blanchard, François Moreau, Bertrand Cariou, et al.
Expert Opinion on Investigational Drugs|July 2, 2021
Anti-diabetic drugs and NASH: from current options to promising perspectivesSarra Smati, Clémence M Canivet, Jérôme Boursier, et al.
Current Atherosclerosis Reports|January 11, 2025
From Genetic Findings to new Intestinal Molecular Targets in Lipid MetabolismCédric Le May, Simon Ducheix, Bertrand Cariou, et al.
Endocrinology|February 17, 2005
Farnesoid X receptor: a new player in glucose metabolism?Bertrand Cariou, Daniel Duran-Sandoval, Folkert Kuipers, et al.
Current Atherosclerosis Reports|July 23, 2014
Congenital lipodystrophies and dyslipidemiasXavier Prieur, Cedric Le May, Jocelyne Magré, et al.
Pageof 32

Showing results (41-50 of 311) with videos related to

Sort By:
Pageof 32
Journal of Clinical Lipidology|April 11, 2017
Severe decrease in high-density lipoprotein cholesterol with the combination of fibrates and ezetimibe: A case seriesEstelle Nobecourt, Bertrand Cariou, Gilles Lambert, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 22, 2021
Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: A narrative reviewSamuel Frey, Éric Mirallié, Bertrand Cariou, et al.
Current Opinion in Lipidology|April 19, 2015
Role of PCSK9 beyond liver involvementBertrand Cariou, Karim Si-Tayeb, Cédric Le May
Frontiers in Endocrinology|November 14, 2018
Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of GlucoseSimon Ducheix, Jocelyne Magré, Bertrand Cariou, et al.
Diabetes Care|April 24, 2025
Response to Comment on Christiaens et al. Diabetes Overtreatment and Hypoglycemia in Older Patients With Type 2 Diabetes on Insulin Therapy: Insights From the HYPOAGE Cohort Study. Diabetes Care 2025;48:61-66Antoine Christiaens, Anne-Sophie Boureau, Samy Hadjadj, et al.
Medecine Sciences : M/S|October 15, 2014
[Trans-intestinal cholesterol excretion (TICE): a new route for cholesterol excretion]Claire Blanchard, François Moreau, Bertrand Cariou, et al.
Expert Opinion on Investigational Drugs|July 2, 2021
Anti-diabetic drugs and NASH: from current options to promising perspectivesSarra Smati, Clémence M Canivet, Jérôme Boursier, et al.
Current Atherosclerosis Reports|January 11, 2025
From Genetic Findings to new Intestinal Molecular Targets in Lipid MetabolismCédric Le May, Simon Ducheix, Bertrand Cariou, et al.
Endocrinology|February 17, 2005
Farnesoid X receptor: a new player in glucose metabolism?Bertrand Cariou, Daniel Duran-Sandoval, Folkert Kuipers, et al.
Current Atherosclerosis Reports|July 23, 2014
Congenital lipodystrophies and dyslipidemiasXavier Prieur, Cedric Le May, Jocelyne Magré, et al.
Pageof 32